Elvira Salarda, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Sparta Medical Office, 215 South Burns, Sparta, IL 62286 Phone: 618-443-4889 |
David Taewoong Chung, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 N Market St, Sparta, IL 62286 Phone: 618-443-4138 Fax: 618-443-2956 |
Dr. Scott I Barclay, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 N Market St, Sparta, IL 62286 Phone: 618-443-1337 Fax: 618-443-1383 |
Russell Coulter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Family Health Centre, 207 South Burns Ave, Sparta, IL 62286 Phone: 618-443-3084 |
Febijesusola Deborah Oyelana, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 818 E Broadway St, Sparta, IL 62286 Phone: 618-443-2177 |
Dr. Carl Setford Schlageter, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 612 E Broadway St, Sparta, IL 62286 Phone: 618-443-3234 Fax: 618-443-3234 |
News Archive
Did you know that when you pick up a product promoted as trans fat free, you may still be ingesting a significant amount of this potentially harmful substance? An article by Case Western Reserve University School of Medicine student Eric Brandt, published in the January/February 2011 issue of the American Journal of Health Promotion, reveals that misleading labeling practices can result in medically significant intake of harmful trans fat, despite what you read on Food and Drug Administration (FDA) approved labels.
African Americans, Hispanics, and those who receive care at a community hospital are all significantly less likely than other patients to receive treatment for early stage non-small cell lung cancer, according to a report in the Journal of Thoracic Oncology.
Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly used to treat lung cancer patients with EGFR mutations, according to new research from The University of Texas MD Anderson Cancer Center.
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
› Verified 9 days ago